CoChat

Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial

Open access
Pereira, S. P., O'Donohue, J., Moniz, C., Phillips, M. G., Abraha, H., Buxton‐Thomas, M., Williams, R. · 2004 · Alimentary Pharmacology & Therapeutics
Cited by 49

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Background : Retrospective studies have suggested that hormone replacement therapy may reduce the rate of bone loss in primary biliary cirrhosis, but no controlled data are available. Methods : Forty‐two post‐menopausal women with primary biliary cirrhosis were treated with calcium and vitamin D, either alone (n = 21) or together with transdermal hormone replacement therapy (n = 21). Bone densitometry was performed at baseline and at 1 year, and serum and urinary markers of bone turnover were measured at three‐monthly intervals. Results : At entry, 17 patients (40%) had spinal or femoral osteopenia (T score − 1 to − 2.5) and nine (21%) had osteoporosis (T < − 2.5). In those given hormone replacement therapy, there was a significant decrease in the mean urinary deoxypyridinoline :creatinine ratios at 3 months (7.8 vs. 6.1 n m/m m creatinine for no hormone replacement therapy vs. hormone replacement therapy; P = 0.04) and a 48% reduction in urinary calcium excretion at 1 year (0.66 vs. 0.32 m m/m m creatinine; P = 0.01). Repeat bone densitometry at 1 year revealed a 2.25% increase in the hormone replacement therapy group (P = 0.02), compared with a non‐significant 0.87% decrease in L2–L4 bone mineral density in those not given hormone replacement therapy. Both treatment regimens were well tolerated, with no increase in cholestasis. Conclusions : Compared with calcium and vitamin D alone, supplemental treatment with transdermal hormone replacement therapy for 1 year improved the vertebral bone density and urinary markers of bone turnover in post‐menopausal women with primary biliary cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2004.01890.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 41

  1. Riggs BL, 1993, The prevention and treatment of osteoporosis, N Engl J Med, 327, 620
  2. 10.1016/0140-6736(90)91801-G · DOI · Paper page
  3. 10.1172/JCI115588 · DOI · Paper page
  4. 10.1016/0140-6736(93)90571-W · DOI
  5. Crippin JS, 1994, Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment, Am J Gastroenterol, 89, 47
  6. 10.1002/hep.1840070420 · DOI
  7. 10.1016/0016-5085(91)90220-F · DOI
  8. 10.1210/jc.83.2.410 · DOI
  9. 10.1056/NEJM199611213352107 · DOI · Paper page
  10. 10.1016/0016-5085(85)90001-0 · DOI
  11. 10.1016/0016-5085(92)91815-L · DOI
  12. World Health Organization., 1994, Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report No. 843.
  13. 10.1111/j.1365-2362.1993.tb00967.x · doi:10.1111/j.1365-2362.1993.tb00967.x
  14. Power MJ, 1989, Solid‐phase enzymoimmunoassay for osteocalcin in human serum or plasma, with use of a monoclonal antibody, Clin Chem, 35, 2087, 10.1093/clinchem/35.10.2087 · doi:10.1093/clinchem/35.10.2087
  15. 10.1016/0016-5085(95)90033-0 · DOI
  16. 10.1002/hep.1840210138 · DOI
  17. 10.7326/0003-4819-103-6-855 · DOI · Paper page
  18. 10.1002/hep.1840070127 · DOI · Paper page
  19. 10.1097/00042737-199903000-00018 · DOI · Paper page
  20. 10.1016/8756-3282(86)90015-3 · DOI
  21. 10.1016/S0016-5085(88)80029-5 · DOI
  22. 10.1210/jcem-69-6-1234 · DOI · Paper page
  23. 10.1016/S1590-8658(03)00078-1 · DOI
  24. 10.1007/s002239900545 · DOI
  25. 10.1016/S1297-319X(02)00364-0 · DOI
  26. 10.1016/S0168-8278(99)80167-6 · DOI
  27. 10.1016/S0016-5085(00)70423-9 · DOI
  28. 10.1053/jhep.2001.22758 · DOI · Paper page
  29. 10.1007/s001980200092 · DOI
  30. 10.1002/hep.1840210219 · DOI · Paper page
  31. 10.1056/NEJM199110243251701 · DOI · Paper page
  32. 10.1136/gut.15.10.788 · DOI
  33. 10.1016/0270-9139(94)90098-1 · DOI
  34. 10.1111/j.1478-3231.1999.tb00034.x · DOI · Paper page
  35. 10.1111/j.1572-0241.2003.07341.x · doi:10.1111/j.1572-0241.2003.07341.x · Paper page
  36. 10.1111/j.1471-0528.1997.tb10638.x · DOI
  37. 10.7326/0003-4819-113-2-95 · DOI · Paper page
  38. 10.1111/j.1471-0528.1994.tb13618.x · DOI
  39. 1996, Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI, J Am Med Assoc, 276, 1389, 10.1001/jama.1996.03540170033029 · DOI · Paper page
  40. 10.1136/bmj.312.7041.1254 · DOI · Paper page
  41. 10.1097/00042737-199908000-00001 · DOI

Cited by

See all 49

Metadata

Authors
Pereira, S. P., O'Donohue, J., Moniz, C., Phillips, M. G., Abraha, H., Buxton‐Thomas, M., & Williams, R.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2004-02-19
Volume
19
Issue
5
Pages
563-570
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1981342139
Cited by
49
References
5
FWCI
2.79
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial. https://app.cochat.ai/papers/10.1111/j.1365-2036.2004.01890.x
The paper
Pereira, S. P., O'Donohue, J., Moniz, C., Phillips, M. G., Abraha, H., Buxton‐Thomas, M., & Williams, R. (2004). Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2004.01890.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.